Price and reimbursement of advanced therapeutic medicinal products in Europe: are assessment and appraisal diverging from expert recommendations?

BACKGROUND: Advanced therapy medicinal products (ATMPs) represent an important cornerstone for innovation in healthcare. However, uncertainty on the value, the high average cost per patient and their one-shot nature has raised a debate on their assessment and appraisal process for pricing and reimbu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ronco, Virginia, Dilecce, Myriam, Lanati, Elena, Canonico, Pier Luigi, Jommi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980570/
https://www.ncbi.nlm.nih.gov/pubmed/33741076
http://dx.doi.org/10.1186/s40545-021-00311-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7980570/
https://www.ncbi.nlm.nih.gov/pubmed/33741076
http://dx.doi.org/10.1186/s40545-021-00311-0

Ejemplares similares